A randomized controlled trial of comparative effectiveness between the 2 dose and 3 dose regimens of hepatitis a vaccine in kidney transplant recipients

Abstract Hepatitis A virus (HAV) is able to cause a spectrum of illnesses ranging from no symptom to fulminant hepatitis which may lead to acute kidney injury. Although hepatitis A vaccine is recommended in non-immune solid organ transplant recipients who live in or travel to endemic areas, the stan...

Full description

Bibliographic Details
Main Authors: Thaninee Prasoppokakorn, Jakapat Vanichanan, Roongruedee Chaiteerakij, Kamonwan Jutivorakool, Suwasin Udomkarnjananun, Krit Pongpirul, Wipusit Taesombat, Salin Wattanatorn, Yingyos Avihingsanon, Kriang Tungsanga, Somchai Eiam-Ong, Kearkiat Praditpornsilpa, Natavudh Townamchai
Format: Article
Language:English
Published: Nature Portfolio 2021-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-020-80052-3